Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Irritable Bowel Syndrome

Free Subscription 30.04.2018 1 An Pediatr (Barc) 1 Ann Nutr Metab 1 Benef Microbes 1 Biomed Res Int 1 Clin Gastroenterol Hepatol 1 Front Psychol 1 Gastroenterology 1 Int Rev Neurobiol 1 J Affect Disord 1 J Clin Gastroenterol 1 J Gastroenterol Hepatol 1 J Med Food 1 J Obes 2 Lancet Gastroenterol Hepatol 1 Mol Med Rep 6 Neurogastroenterol Motil 1 Nurs Res 1 PLoS One 1 Rev Esp Enferm Dig 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

An Pediatr (Barc)

1. BARANGUAN CASTRO ML, Ros Arnal I, Garcia Romero R, Rodriguez Martinez G, et al
   [Implementationof a low FODMAP dietforfunctional abdominal pain].
   An Pediatr (Barc). 2018 Apr 20. pii: S1695-4033(18)30135.
   PubMed     Text format     Abstract available
   
   

   
   Ann Nutr Metab

2. ENCK P, Mazurak N
   Dysbiosis in Functional Bowel Disorders.
   Ann Nutr Metab. 2018;72:296-306.
   PubMed     Text format     Abstract available
   
   

   
   Benef Microbes

3. SUDHA MR, Jayanthi N, Aasin M, Dhanashri RD, et al
   Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
   Benef Microbes. 2018 Apr 26:1-10. doi: 10.3920/BM2017.0129.
   PubMed     Text format     Abstract available
   
   

   
   Biomed Res Int

4. HE F, Wu C, Li P, Li N, et al
   Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation.
   Biomed Res Int. 2018;2018:9171905.
   PubMed     Text format     Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. POHL D, Van Oudenhove L, Tornblom H, Le Neve B, et al
   Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
   Clin Gastroenterol Hepatol. 2018 Apr 24. pii: S1542-3565(18)30395.
   PubMed     Text format     Abstract available
   
   

   
   Front Psychol

6. CARROZZINO D, Porcelli P
   Alexithymia in Gastroenterology and Hepatology: A Systematic Review.
   Front Psychol. 2018;9:470.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

7. LACKNER JM, Jaccard J, Keefer L, Brenner D, et al
   Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
   Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30406.
   PubMed     Text format     Abstract available
   
   

   
   Int Rev Neurobiol

8. ELSENBRUCH S, Labrenz F
   Nocebo Effects and Experimental Models in Visceral Pain.
   Int Rev Neurobiol. 2018;138:285-306.
   PubMed     Text format     Abstract available
   
   

   
   J Affect Disord

9. KUROKAWA S, Kishimoto T, Mizuno S, Masaoka T, et al
   The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
   J Affect Disord. 2018;235:506-512.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Gastroenterol

10. FRANCAVILLA R, Piccolo M, Francavilla A, Polimeno L, et al
    Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
    J Clin Gastroenterol. 2018 Apr 23. doi: 10.1097/MCG.0000000000001023.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

11. GWEE KA, Lee WW, Ling KL, Ooi CJ, et al
    Consensus and contentious statements on the use of probiotics in clinical practice: a South East Asian Gastro-neuro Motility Association Working Team Report.
    J Gastroenterol Hepatol. 2018 Apr 26. doi: 10.1111/jgh.14268.
    PubMed     Text format     Abstract available
    
    

    
    J Med Food

12. CHEN AGY, Offereins MSL, Mulder CJ, Frampton CM, et al
    A Pilot Study of the Effect of Green Kiwifruit on Human Intestinal Fermentation Measured by Hydrogen and Methane Breath Testing.
    J Med Food. 2018 Apr 25. doi: 10.1089/jmf.2018.4179.
    PubMed     Text format     Abstract available
    
    

    
    J Obes

13. AASBRENN M, Lydersen S, Farup PG
    A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study.
    J Obes. 2018;2018:3732753.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

14. VAN TILBURG MAL
    Can we treat visceral hypersensitivity in functional abdominal pain?
    Lancet Gastroenterol Hepatol. 2017 Aug 18. pii: S2468-1253(17)30258.
    PubMed     Text format    
    
    
15. FORD AC
    Stool as a treatment for IBS: more questions than answers?
    Lancet Gastroenterol Hepatol. 2018;3:2-3.
    PubMed     Text format    
    
    

    
    Mol Med Rep

16. KODANI M, Fukui H, Tomita T, Oshima T, et al
    Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSSinduced colitis.
    Mol Med Rep. 2018 Apr 24. doi: 10.3892/mmr.2018.8926.
    PubMed     Text format     Abstract available
    
    

    
    Neurogastroenterol Motil

17. CHANG JY, Almazar AE, Richard Locke G 3rd, Larson JJ, et al
    Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Neurogastroenterol Motil. 2018 Apr 27:e13356. doi: 10.1111/nmo.13356.
    PubMed     Text format     Abstract available
    
    
18. SAPS M, Lavigne JV, van Tilburg MA, Miranda A, et al
    Endpoints, reliability, and meaningful changes in clinical trials for children with irritable bowel syndrome. The Rome foundation pediatric subcommittee on clinical trials.
    Neurogastroenterol Motil. 2018;30:e13308.
    PubMed     Text format    
    
    
19. FUKUDO S, Nakajima A, Fujiyama Y, Kosako M, et al
    Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation.
    Neurogastroenterol Motil. 2018;30:e13363.
    PubMed     Text format    
    
    
20. ZWEIG A, Schindler V, Becker AS, van Maren A, et al
    Higher prevalence of joint hypermobility in constipation predominant irritable bowel syndrome.
    Neurogastroenterol Motil. 2018 Apr 23:e13353. doi: 10.1111/nmo.13353.
    PubMed     Text format     Abstract available
    
    
21. SHEARER J, Paine P, Agrawal A, Ford AC, et al
    Efficacy of linaclotide in irritable bowel syndrome with constipation: Real-world data.
    Neurogastroenterol Motil. 2018;30:e13328.
    PubMed     Text format    
    
    
22. COLLIGNON O, Petavy F
    Statistical considerations about the design and endpoints of randomized clinical trials for children with irritable bowel syndrome.
    Neurogastroenterol Motil. 2018;30:e13266.
    PubMed     Text format    
    
    

    
    Nurs Res

23. WEAVER KR, Melkus GE, Fletcher J, Henderson WA, et al
    Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.
    Nurs Res. 2018;67:261-267.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

24. ZHU L, Ma Y, Deng X
    Comparison of acupuncture and other drugs for chronic constipation: A network meta-analysis.
    PLoS One. 2018;13:e0196128.
    PubMed     Text format     Abstract available
    
    

    
    Rev Esp Enferm Dig

25. GEIJO MARTINEZ F, Sanchez Garrido A, Marcos Prieto H, Pineiro Perez C, et al
    Long-term results of linaclotide in the treatment of constipation-type irritable bowel syndrome.
    Rev Esp Enferm Dig. 2018;110.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

26. ZOLLER B, Ohlsson H, Waehrens R, Sundquist J, et al
    Association of irritable bowel syndrome and venous thromboembolism.
    Scand J Gastroenterol. 2018 Apr 24:1-6. doi: 10.1080/00365521.2018.1465118.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: